| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,612 | 16,433 | 13,228 | 24,884 | | Cost of Revenue | 17,546 | 11,578 | 12,716 | 17,755 | | | Gross Profit | 3,066 | 4,855 | 512 | 7,129 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,275 | 5,071 | 5,566 | 6,365 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 872 | 889 | 856 | 888 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (81) | (1,105) | (5,910) | (124) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,006 | 1,989 | 413 | 1,153 | | Earnings Before Interest And Taxes | 2,533 | 884 | (5,497) | 1,029 | | Interest Expense | (870) | 1,024 | 219 | 385 | | Income Before Tax | 3,403 | (140) | (5,716) | 644 | | Income Tax Expense | 2,114 | (231) | (810) | 210 | | Minority Interest |
-
|
-
|
-
| (635) | | | | Net Income From Continuing Ops | 2,533 | 91 | (4,906) | (201) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,533 | 91 | (4,906) | (201) | | Preferred Stock And Other Adjustments | (2,572) | (291) | 2,863 |
-
| | | Net Income Applicable To Common Shares | ($39) | ($200) | ($2,043) | ($201) |
|
0.31% Nasdaq 
0.05%
Income Statement
